Issue 2 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

31

No.

2

February 29, 2008Feb 29, 2008

Free

DOWNLOAD THE PDF

Large Phase III Trial Seeks Optimal Use Of Tykerb vs. Herceptin In Breast Cancer

Most Older Men With Early Prostate Cancer Can Avoid Treatment, Analysis Finds

Extent Of Risk Reduction From Ovary Removal Varies According To BRCA Mutation

Smoking Increases Breast Cancer Risk Based on Genes

Larynx Preservation Provides Better Voice Quality For Patients

PET Better At Evaluating Response In Sarcoma

Sorafenib Targets AML Driven By Mutant FLT3 Gene

NCI Cooperative Group, Cancer Center Trials Listed

Recent Issues

Volume 52 | Issue 26 - July 02, 2026

Volume 52 | Issue 25 - June 26, 2026

Volume 52 | Issue 24 - June 18, 2026

Volume 52 | Issue 23 - June 12, 2026

Volume 52 | Issue 22 - June 05, 2026

Volume 52 | Issue 21 - May 29, 2026